Early studies focused on single-hormone pathways, particularly GLP-1
Most clinical trials are conducted using standard, increasing therapeutic doses, meaning the effectiveness and safety of very low doses are largely unstudied and unvalidated
Trimi names VialsRx with Texas Board of Pharmacy license #35264 and GreenwichRx
Unlike GLP-1, GIP can promote glucagon secretion in normal and hypoglycemic states, and inhibit it in hyperglycemia, thus acting as a bifunctional hormone to maintain blood glucose homeostasis
Additionally, these efficacious capsules contain a digestive enzyme blend that supports healthy digestion and nutrient uptake, which is key for optimum wellness when food intake is reduced
TC10 Attenuates Cognitive Decline via GLP-1 (2025) This 2025 Scientific Reports (Nature Publishing Group) study is the first to demonstrate that TC10's cognitive protective effects in mice are GLP-1-dependent distinguishing TC10's mechanism from TC8's ketone-based pathway
